E-Therapeutics PLC

E-Therapeutics PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)14.35
  • Today's Change0.00 / 0.00%
  • Shares traded1.34k
  • 1 Year change485.71%
  • Beta-1.3509
Data delayed at least 20 minutes, as of Oct 26 2020 08:03 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade E-Therapeutics PLC (ETX:LSE) traded at 14.35, -37.61% below its 52-week high of 23.00, set on May 28, 2020.
52-week range
2.50Oct 28 201923.00May 28 2020
Previous close14.35
Average volume587.64k
Shares outstanding419.06m
Free float181.82m
P/E (TTM)--
Market cap60.13m GBP
EPS (TTM)-0.0096
Data delayed at least 20 minutes, as of Oct 26 2020 08:03 BST.
More ▼

Investors Chronicle View

The last IC recommendation on E-Therapeutics PLC shares was Hold at 15.50 on 04 Apr 2016Read the full article

Board of Directors


Ali Mortazavi, Executive Chairman


Professor Trevor Jones CBE, Non-Executive Director


Michael Bretherton, Non-Executive Director


Oxford Office and Registered Office:
e-therapeutics plc
17 Blenheim Office Park
Long Hanborough
OX29 8LN

Newcastle Office:
e-therapeutics plc
City Quadrant
11 Waterloo Square
Newcastle Upon Tyne

General Enquiries
E: contact@etherapeutics.co.uk

T: +44 (0) 1993 880000
F: +44 (0) 1993 880207

The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.